ES2094166T3 - Compuestos azatetraciclicos. - Google Patents

Compuestos azatetraciclicos.

Info

Publication number
ES2094166T3
ES2094166T3 ES91106697T ES91106697T ES2094166T3 ES 2094166 T3 ES2094166 T3 ES 2094166T3 ES 91106697 T ES91106697 T ES 91106697T ES 91106697 T ES91106697 T ES 91106697T ES 2094166 T3 ES2094166 T3 ES 2094166T3
Authority
ES
Spain
Prior art keywords
compounds
azatetraciclic
azatetraciclo
mammals
addressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106697T
Other languages
English (en)
Inventor
Daniel Paul Becker
Daniel Lee Flynn
Roger Nosal
Dale P Spangler
Daniel Lamar Zabrowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2094166T3 publication Critical patent/ES2094166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ESTA INVENCION SE DIRIGE A COMPUESTOS DE AZATETRACICLO DE LA FORMULA GENERAL DONDE A PUEDE SER NH O UN ENLACE COVALENTE, DONDE P PUEDE SER 1 O 0, AR REPRESENTA UNA MITAD AROMATICA COMO SE TRATARA AQUI MAS TARDE, B REPRESENTA NH U O Y D REPRESENTA LA ESTRUCTURA TETRACICLICA. O ESTOS COMPUESTOS SON UTILES PARA TRATAR TRANSTORNOS DE MOTILIDAD GASTROINTESTINAL EN MAMIFEROS.
ES91106697T 1990-04-27 1991-04-25 Compuestos azatetraciclicos. Expired - Lifetime ES2094166T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51539190A 1990-04-27 1990-04-27
US07/682,993 US5140023A (en) 1990-04-27 1991-04-12 Azatetracycle compounds

Publications (1)

Publication Number Publication Date
ES2094166T3 true ES2094166T3 (es) 1997-01-16

Family

ID=27058488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106697T Expired - Lifetime ES2094166T3 (es) 1990-04-27 1991-04-25 Compuestos azatetraciclicos.

Country Status (18)

Country Link
US (2) US5140023A (es)
EP (1) EP0454121B1 (es)
JP (1) JP3145728B2 (es)
KR (1) KR0183423B1 (es)
AT (1) ATE145207T1 (es)
AU (1) AU630555B2 (es)
CA (1) CA2041224C (es)
DE (1) DE69123076T2 (es)
DK (1) DK0454121T3 (es)
ES (1) ES2094166T3 (es)
FI (1) FI94530C (es)
GR (1) GR3021607T3 (es)
IE (1) IE76450B1 (es)
IL (1) IL97952A0 (es)
NO (1) NO178765C (es)
NZ (1) NZ237948A (es)
PT (1) PT97486B (es)
ZA (1) ZA913135B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2082415A1 (en) * 1991-03-07 1992-09-08 Daniel P. Becker Meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
US5516782A (en) * 1991-03-07 1996-05-14 G. D. Searle & Co. New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
US5234921A (en) * 1991-03-07 1993-08-10 G. D. Searle & Co. Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof as pharmaceuticals
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
US5840903A (en) * 1992-07-27 1998-11-24 G. D. Searle & Co. 4-aminomethyl-1-azaadamantane derived benzamides
US5354757A (en) * 1992-12-15 1994-10-11 G. D. Searle & Co. Azanoradamantanes
US5541344A (en) * 1994-06-30 1996-07-30 G. D. Searle & Co. Intermediates useful in a process for the preparation of azanoradamantane benzamides
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US6638928B1 (en) * 2002-12-03 2003-10-28 Vela Pharmaceuticals, Inc. Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
GB0321091D0 (en) * 2003-09-09 2003-10-08 Alizyme Therapeutics Ltd Synthesis
JP2010520875A (ja) 2007-03-09 2010-06-17 レノビス， インコーポレイテッド Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびその使用
ATE509931T1 (de) * 2007-03-23 2011-06-15 Abbott Lab Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
GB2111479A (en) * 1981-10-01 1983-07-06 Beecham Group Plc Benzamides
EP0093488A3 (en) * 1982-03-18 1984-05-23 Beecham Group Plc Nortropyl benzopyrrolinone compounds, process for their preparation and pharmaceutical compositions containing them
NZ203861A (en) * 1982-04-14 1986-07-11 Beecham Group Plc Bicyclic heterocyclic compounds and pharmaceutical compositions containing such
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
BG48681A3 (bg) * 1982-12-14 1991-04-15 Ciba - Geigy Ag Фунгицидно средство
DE3429830A1 (de) * 1983-08-26 1985-03-07 Sandoz-Patent-GmbH, 7850 Lörrach Automatische carbonsaeure- und sulfonsaeureester oder -amide
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
EP0189002B1 (en) * 1984-12-20 1993-03-03 Sandoz Ag Treatment of gastrointestinal disorders using 5-ht3 antagonists
CH667657A5 (de) * 1985-01-07 1988-10-31 Sandoz Ag Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
DE201165T1 (de) * 1985-03-14 1989-04-20 Beecham Group P.L.C., Brentford Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
GB8523211D0 (en) * 1985-09-19 1985-10-23 Beecham Group Plc Compounds
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
ES2053451T3 (es) * 1986-01-07 1994-08-01 Beecham Group Plc Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
EP0235878A3 (en) * 1986-01-16 1989-06-14 Beecham Group Plc Novel compounds
EP0315390B1 (en) * 1987-11-04 1994-07-20 Beecham Group Plc Novel 4-oxobenzotriazines and 4-oxoquinazolines
IE62231B1 (en) * 1987-12-24 1995-01-11 Wyeth John & Brother Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
JP3145728B2 (ja) 2001-03-12
DE69123076T2 (de) 1997-04-03
FI94530B (fi) 1995-06-15
EP0454121A3 (en) 1992-07-08
DK0454121T3 (da) 1996-12-02
USRE35218E (en) 1996-04-23
CA2041224A1 (en) 1991-10-28
PT97486A (pt) 1992-01-31
FI912013A0 (fi) 1991-04-25
IE911420A1 (en) 1991-11-06
NO178765C (no) 1996-05-29
KR910018382A (ko) 1991-11-30
EP0454121B1 (en) 1996-11-13
NO911648D0 (no) 1991-04-25
US5140023A (en) 1992-08-18
EP0454121A2 (en) 1991-10-30
IE76450B1 (en) 1997-10-22
GR3021607T3 (en) 1997-02-28
IL97952A0 (en) 1992-06-21
ZA913135B (en) 1992-07-29
JPH04225979A (ja) 1992-08-14
PT97486B (pt) 1998-08-31
NO911648L (no) 1991-10-28
NO178765B (no) 1996-02-19
AU630555B2 (en) 1992-10-29
ATE145207T1 (de) 1996-11-15
AU7595191A (en) 1991-11-07
CA2041224C (en) 2002-07-09
KR0183423B1 (ko) 1999-05-01
NZ237948A (en) 1994-05-26
FI912013L (fi) 1991-10-28
FI94530C (fi) 1995-09-25
DE69123076D1 (de) 1996-12-19

Similar Documents

Publication Publication Date Title
ES2094166T3 (es) Compuestos azatetraciclicos.
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
ES506400A0 (es) Procedimiento para la fabricacion de collares para animales caseros,conteniendo ectoparasiticidas
ES2096639T3 (es) Derivados de benzofurano, benzotiofeno, indol o indolizina, su procedimiento de preparacion, asi como las composiciones que los contienen.
DE59814355D1 (de) Herstellung von organischen elektrolumineszierenden Bauteilen
FI871768A0 (fi) Mjukgoerande detergentkompositioner innehaollande amidmjukgoeringsmedel.
ES2052463T1 (es) Antihipercolesterolemicos.
NO923710D0 (no) N-alkyl-3-fenyl-3-(2-alkyltiofenoksy)propylaminer
ES2189993T3 (es) Sulfamidas de aminoacilo para el tratamiento de trastornos hiperproliferativos.
ATE258486T1 (de) Holzbehandlungsverfahren
ATE108446T1 (de) Ringsubstituierte 2-amin-1,2,3,4-tetrahydro- naphthaline.
DE3881633D1 (de) Flammbehandelte monofilamente.
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
EA200100152A1 (ru) Замещенные пиперазиноны и их терапевтическое применение
SE8502865D0 (sv) Naphtoxazine, ihre herstellung und verwendung
SE9001111D0 (sv) Supportive use
ES2077358T3 (es) N-alquil-3-fenil-3-(2-alquiltiofenoxi)propilaminas.
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré
BG36492A3 (en) Fungicide means
ES2111330T3 (es) Derivados de 5-(1-fluor-vinil)-1h-pirimidina-2,4-diona que son utiles como agentes neoplasicos.
PT100026A (pt) Poliamina-fenois com accao radioprotectora
EA200001105A1 (ru) 10-камфорсульфонат пароксетина для лечения нарушений цнс
ES2150682T3 (es) Sulfonilamino(tio)carboniltriazolinonas con heterocicliloxi-substituyentes.
ATE59218T1 (de) Kettenglied fur energiezufuhrungskette.
ATE26401T1 (de) Behandlung gegen thrombose.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 454121

Country of ref document: ES